Gyre Therapeutics Inc. Capital Reinvestment Ratio
Gyre Therapeutics Inc. capital reinvestment ratio. Gyre Therapeutics Inc. (GYRE) has a Capital Reinvestment Ratio of 0.06x as of March 2026, meaning it reinvests 0% of its operating cash flow ($3.18 Million) in capital expenditures ($178.00K). Check Gyre Therapeutics Inc. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Gyre Therapeutics Inc. (2007–2025)
Capital reinvestment ratio of Gyre Therapeutics Inc. from 2007 to 2025. This chart tracks Gyre Therapeutics Inc.'s Capital Reinvestment Ratio across 5 annual periods. Also explore Gyre Therapeutics Inc. equity growth rate to track the company's year-over-year net asset growth rate.
Gyre Therapeutics Inc. Capital Reinvestment Ratio by Year (2007–2025)
Gyre Therapeutics Inc. capital reinvestment ratio by year from 2007 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Gyre Therapeutics Inc..
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.18x | $1.01 Million | $1.19 Million | ▲ +255.3% |
| 2023 | 0.33x | $25.89 Million | $8.59 Million | ▼ -29.2% |
| 2022 | 0.47x | $10.68 Million | $5.00 Million | ▲ +1855.3% |
| 2010 | 0.02x | $138.30 Million | $3.31 Million | ▼ -88.0% |
| 2007 | 0.20x | $24.84 Million | $4.94 Million | — |